Physician profile
Roberto Rey Dios
NPI 1487835211
$3,522.91
in general payments reported to CMS, 2019-2025
12 companies · $891 in 2025
The $891 reported for 2025 was more than what a typical Neurological Surgery provider received nationally (typical 2025 total: $604).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $1,352 · 2020: $14.51 · 2023: $1,069 · 2024: $197 · 2025: $891.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Travel and Lodging: $1,286 · Food and Beverage: $870.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Travel and Lodging | $1,286.33 |
| Food and Beverage | $869.61 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Nuvasive, INC. | $1,068.76 | 2023 | Alif, Xlif |
| Medtronic USA, INC. | $871.89 | 2019 | |
| Providence Medical Technology, INC. | $619.12 | 2025 | |
| Globus Medical, INC. | $306.85 | 2024-2025 | Excelsius Gps, Caliber L, Reline |
| Integra Lifesciences Corporation | $270.24 | 2019 | |
| Stryker Corporation | $110.22 | 2019-2024 | Everest Spinal System |
| Medical Device Business Services, INC. | $91.49 | 2019 | |
| Depuy Synthes Sales INC. | $72.69 | 2020-2025 | Matrixneuro |
| Medtronic, INC. | $41.50 | 2025 | Unid_pass |
| Molnlycke Health Care US, LLC | $31.88 | 2025 | Mepilex Lite, Mepilex Border Post-Op, Mlnlyckez-Flo Fluidized Positioner |
| Csl Behring | $22.31 | 2019 | |
| Ethicon US, LLC | $15.96 | 2024 | Stratafix, Surgicel Nu-Knit |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Roberto Rey Dios listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.